The fungal secondary metabolite trichodimerol inhibits TGF-β dependent cellular effects and tube formation of MDA-MB-231 cells Annegret SerweTimm AnkeGerhard Erkel PRECLINICAL STUDIES 14 November 2008 Pages: 491 - 502
Regression of Dalton’s lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand Raj K. KoiriSurendra K. TrigunSantosh K. Dubey PRECLINICAL STUDIES 29 November 2008 Pages: 503 - 516
Boldine: a potential new antiproliferative drug against glioma cell lines Daniéli GerhardtAna Paula HornChristianne Salbego PRECLINICAL STUDIES 03 December 2008 Pages: 517 - 525
Inhibitory effect of tea polyphenols on hepatic preneoplastic foci in Wistar rats Smita SrivastavaMadhulika SinghYogeshwer Shukla PRECLINICAL STUDIES 05 December 2008 Pages: 526 - 533
Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: A structure–activity relationship study S. B. Benaka PrasadK. VinayaK. S. Rangappa PRECLINICAL STUDIES 06 December 2008 Pages: 534 - 542
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis Ansgar BrüningPetra BurgerAlexander Burges PRECLINICAL STUDIES 28 November 2008 Pages: 543 - 551
“Classical 3 + 3 design” versus “accelerated titration designs”: analysis of 270 phase 1 trials investigating anti-cancer agents Nicolas PenelNicolas IsambertJacques Bonneterre PHASE I STUDIES 10 January 2009 Pages: 552 - 556
Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol Clovis O. Da FonsecaJulio Thome SilvaThereza Quirico-Santos PHASE I STUDIES 13 January 2009 Pages: 557 - 564
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen Lida MinaIan KropKathy D. Miller PHASE II STUDIES 13 February 2009 Pages: 565 - 570
Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer Bryan J. SchneiderFrancis P. WordenGregory P. Kalemkerian PHASE II STUDIES 19 February 2009 Pages: 571 - 578
Trastuzumab-induced CCL20 and interleukin-8 mRNA in human whole blood ex vivo Setsuo HasegawaHideaki KatoMasato Mitsuhashi SHORT REPORT 10 February 2009 Pages: 579 - 582
Wound healing delay after central venous access following DCF/VEGF-trap therapy Charles FertéChristophe MassardJean-Charles Soria SHORT REPORT 17 February 2009 Pages: 583 - 585
Cyclin-dependent kinase inhibitors as potential targeted anticancer agents Ivan Diaz-PadillaLillian L. SiuIgnacio Duran Review 05 March 2009 Pages: 586 - 594